Product Information
OMNARIS 50 MCG NASAL SPRAY is a brand product labeled by Covis Pharma US, Inc, priced at $22.5531 per GM under NDC 70515070101. Its NADAC has been published 404 times since Jan 9, 2019.
FDA first approved this application on Oct 20, 2006.
Strength
50 ug/1
Manufacturer
Covis Pharma US, IncNDC
70515070101
Classification
Brand
Dosage Form
SPRAY
Route
NASAL
Effective Date
9/23/2026
Active Ingredients
CICLESONIDEApproval Type
New Drug (NDA)
FDA Application
NDA022004FDA Approved
10/20/2006
On Market Since
4/23/2018
Price Statistics
The NADAC for OMNARIS 50 MCG NASAL SPRAY has been published 404 times since Jan 9, 2019, and over the history we have for it it has risen 4.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $22.5531 per GM |
|---|---|
| All-time high | $22.8283 (May 10, 2023) |
| All-time low | $21.4544 (Mar 20, 2019) |
| 52-week high | $22.6232 |
| 52-week low | $22.5531 |
| Median price | $22.5833 |
| Average price | $22.4733 |
| Largest weekly change | +5.0% (Jan 1, 2020) |
| Weeks tracked | 404 |
| Tracking since | Jan 9, 2019 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the ciclesonide market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Covis Pharma US, Inc manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
ciclesonide market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of OMNARIS 50 MCG NASAL SPRAY?
The current National Average Drug Acquisition Cost (NADAC) for OMNARIS 50 MCG NASAL SPRAY, manufactured by Covis Pharma US, Inc, is $22.5531 per GM (NDC 70515070101), effective Sep 30, 2026.
How has the price of OMNARIS 50 MCG NASAL SPRAY changed over time?
Over the history we have for it, the NADAC for OMNARIS 50 MCG NASAL SPRAY has risen 4.6%. It has been tracked across 404 weekly CMS publications since Jan 9, 2019.
What are the highest and lowest recorded NADAC prices for OMNARIS 50 MCG NASAL SPRAY?
Since Jan 9, 2019, the NADAC for OMNARIS 50 MCG NASAL SPRAY has ranged from a low of $21.4544 (Mar 20, 2019) to a high of $22.8283 (May 10, 2023), with a median of $22.5833 per GM.
Are there cheaper alternatives to OMNARIS 50 MCG NASAL SPRAY?
No other NADAC-published product currently shares the active ingredient and strength of OMNARIS 50 MCG NASAL SPRAY in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures OMNARIS 50 MCG NASAL SPRAY?
OMNARIS 50 MCG NASAL SPRAY (NDC 70515070101) is labeled by Covis Pharma US, Inc, and CMS classifies it as a brand product.